��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Long-Term Efficacy of Alglucosidase Alfa in Late-Onset Pompe Disease

Topic Neuromuscular and Clinical Neurophysiology (EMG)

Presentation(s) P1 - (-)

Poster/Presentation
Number 120

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Paula R. Clemens, MD (Univ of Pittsburgh/ Dept of Neurology) PRESENTER	The institution of Dr. Clemens has received research support from NS Pharma. The institution of Dr. Clemens has received research support from ReveraGen. The institution of Dr. Clemens has received research support from Amicus. The institution of Dr. Clemens has received research support from Sanofi. The institution of Dr. Clemens has received research support from Spark. The institution of Dr. Clemens has received research support from NIH. The institution of Dr. Clemens has received research support from MDA. The institution of Dr. Clemens has received research support from FDA.
Pascal Laforet (Hopital Pitie Salpetriere)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Ans Van Der Ploeg (Metabolic Disease and Genetics, Erasmus Medic)	The institution of Ans Van Der Ploeg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . The institution of Ans Van Der Ploeg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Ans Van Der Ploeg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics . The institution of Ans Van Der Ploeg has received research support from Sanofi Genzyme.